VKTX News and Press, Viking Therapeutics Inc. From 02/24/26

2026-02-24 14:30:38 ET Intro I think everyone agrees that things have been genuinely tough for Hims & Hers Health, Inc. ( HIMS ), and its shareholders lately— the stock is down more than 75% after touching all‑time highs above $60 as recently as last October. I...

2026-02-23 20:50:00 ET If you're looking to capitalize on the rapidly growing market for weight loss drugs, you can do so in different ways. One strategy is to invest in companies like Eli Lilly or Novo Nordisk that already dominate this space. Another is to target smaller biotechs ...

2026-02-23 13:03:19 ET If you're looking for the company-specific headline that sent shares of Viking Therapeutics (NASDAQ: VKTX) soaring today, don't bother. You won't find one. Rather, investors are proverbially connecting dots based on other pharmaceutical companies ' headlin...

2026-02-23 05:30:00 ET The weight loss drug market has been one key focus for investors in recent years. This is because demand has been incredibly high, driving blockbuster revenue for companies making such products -- here, I'm talking about pharma giants Eli Lilly and Novo Nordisk ...

2026-02-19 18:30:00 ET If you're looking to add a bit of growth to your portfolio, you may turn to well-recognized growth companies that already generate major revenue -- or you could turn to the potential winners of tomorrow. Both types of companies make good additions. The former offers y...

2026-02-19 15:43:00 ET Most veteran investors can attest that, although they're also often a complete bust, every now and then a biopharma stock dishes out a windfall gain. That's what the analyst community seems to expect from Viking Therapeutics (NASDAQ: VKTX) in the foreseeab...

2026-02-18 16:51:24 ET Intro I think it's good to start with taking the line from my last piece, which, to me, describes Structure Therapeutics Inc. ( GPCR ) as a business really well: It is a GLP‑1 oral pure play trying to access one of today’s largest and faste...

2026-02-17 08:35:00 ET Viking Therapeutics (NASDAQ: VKTX) is aiming to join one of the biggest growth industries of the times: the weight loss drug market. People hoping to lose weight have rushed to get in on GLP-1 drugs, a type of product that has proven its efficacy in clinical t...

2026-02-14 08:44:30 ET The GLP-1 sector has seen a lot of drama over the last month, while Viking Therapeutics, Inc. ( VKTX ) is full-speed ahead with market-leading therapeutics. The weight-loss sector has seen initial promising signs from the launch of oral GLP-1 versions, in anot...

Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market Canada NewsWire ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER, BC , Feb. 13, 2026 /CNW/ -- Equity-Insider.com News Commentary – The global health and wellness sector is entering 2...